| abstract |
Disclosed is the of a Eucalyptus extract comprises at least one compound of formula (I), wherein the substituents are defined in the specification, or any one of the diastereoisomeric forms thereof, in the preparation of a medicament or of a food supplement for the treatment and/or prevention of neurological or psychiatric diseases or pathologies and related disorders, of functional somatic syndromes and of dependence on addictive substances, arising from a disorder of dopamine and/or serotonin and/or noradrenaline reuptake. |